search again

Idecabtagene Vicleucel (Abecma), up to 460 Million Cells

Nationwide rates for HCPCS C9081

Idecabtagene vicleucel, up to 460 million autologous anti-BCMA CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $436,516 · 10th–90th $9,333$436,5160%50%10th$436,516Professionalmedian $426,580 · 10th–90th $426,580$501,1870%50%90th$426,580$50.0$200.0$1.0K$5.0K$20.0K$100.0K$500.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
United
Setting
Facility
Modifier
Global
Typical Low
$1,258.93
Median
$1,258.93
Typical High
$1,258.93
United
Setting
Professional
Modifier
Global
Typical Low
$501,187.23
Median
$501,187.23
Typical High
$630,957.34